{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:35Z","timestamp":1787026955255,"version":"build-2736575974"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>H3 K27-Altered Diffuse Midline Gliomas are commonly found in children and adolescents in midline locations such as the thalamus, brain stem, and spinal cord. It is rare for these tumors to affect adults and to occur in locations like the lateral ventricles. Despite aggressive treatment methodologies, there is no cure for this disease. The median survival is between 8-12 months. A 24-year-old white male presented to the emergency department due to severe headache refractory to pain medications with a 2-month history of progressive headaches and eventual memory problems. Computed tomography (CT) and magnetic resonance imaging (MRI) showed an intraventricular enhancing mass and hydrocephalus. The final diagnosis was an intraventricular H3 K27-Altered Diffuse Midline Glioma. The patient underwent two craniotomies, one laser interstitial thermal ablation (LITT), chemoradiotherapy, and bevacizumab and ONC206, through compassionate use. Despite a reduction in the tumor size, it continued to spread to other brain areas, leading to further complications and, eventually, his death, 10 months after initial diagnosis. From review of the literature, 21 cases were identified, and the median age was 24. Their median survival is 10.5 months (ranges 1 - 24 months). This case report presents the clinical, radiological, pathological, and molecular characteristics of a 24-year-old white man diagnosed with a ventricular H3 K27-Altered diffuse midline glioma, highlighting the rare presentation, management, and outcomes.<\/jats:p>","DOI":"10.3389\/fonc.2025.1477978","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T03:41:23Z","timestamp":1742442083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Rare intraventricular H3 K27-altered diffuse midline glioma in an adult"],"prefix":"10.3389","volume":"15","author":[{"given":"Merari","family":"Jasso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay-Jiguang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi B.","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgene W.","family":"Hergenroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2022.06.020","article-title":"H3K27-altered diffuse midline gliomas among adult patients: A systematic review of clinical features and survival analysis","volume":"165","author":"Bin-Alamer","year":"2022","journal-title":"World Neurosurg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.humpath.2018.04.015","article-title":"H3 K27M\u2013mutant diffuse midline gliomas in different anatomical locations","volume":"78","author":"Wang","year":"2018","journal-title":"Hum Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad220","article-title":"H3 K27M-altered glioma and diffuse intrinsic pontine glioma: semi-systematic review of treatment landscape and future directions","volume":"26","author":"van den Bent","year":"2023","journal-title":"Neuro-oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nly006","article-title":"Adult brainstem gliomas with H3K27M mutation: radiology, pathology and prognosis","volume":"77","author":"Daoud","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.602553","article-title":"Clinical features and molecular markers on diffuse midline gliomas with H3K27M mutations: A 43 cases retrospective cohort study","volume":"10","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202003_20527","article-title":"H3K27M mutant diffuse midline glioma: a case report","volume":"24","author":"Luo","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/qims-22-339","article-title":"A rare presentation of primary lateral ventricle H3 K27-altered diffuse midline glioma in a 14-year-old girl: a case description","volume":"12","author":"Zhao","year":"2022","journal-title":"Quantitative Imaging Med Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001897","article-title":"Diffuse midline gliomas with histone H3 K27M mutation in adults and children: A retrospective series of 164 cases","volume":"46","author":"Zheng","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02036","article-title":"Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline","volume":"40","author":"Mohile","year":"2022","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/noajnl\/vdaa142","article-title":"Clinical, radiologic and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults","volume":"2","author":"Schulte","year":"2020","journal-title":"Neuro-Oncol Adv"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14307","article-title":"Differences in survival prognosticators between children and adults with H3K27M-mutant diffuse midline glioma","volume":"29","author":"Gong","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1082062","article-title":"Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type","volume":"12","author":"Vallero","year":"2023","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1477978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T03:41:26Z","timestamp":1742442086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1477978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":13,"alternative-id":["10.3389\/fonc.2025.1477978"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1477978","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"article-number":"1477978"}}